ReShape Lifesciences Inc. - RSLS Net earnings per share for the last four quarters

ReShape Lifesciences, Inc. (RSLS) - corporate logo

ReShape Lifesciences (RSLS) dominates the minimally invasive obesity therapy segment by leveraging its recognized Lap-Band technology. The annual EPS growth rate over the last 12 months reflects profit dynamics, where 76.80 indicates the current value of the metric. However, stringent FDA oversight and patent protections create high barriers to entry, while liquidity shortages and small sales scale hinder the company's path to break-even.

ReShape Lifesciences Inc. (RSLS) Net earnings per share for the last 12 months: for the period 02/11/2024 - 02/20/2024

ReShape Lifesciences Inc - analytical breakdowns and key metrics (RSLS)

- stock price and consensus target price:
Price reshapelifesciences.com|RSLS - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization ReShape Lifesciences Inc|RSLS - Enterprise Value
- book value of equity indicators:
Accounting Value per Share ReShape Lifesciences|RSLS - Company Net Assets|Market Value to Book Value reshapelifesciences.com|RSLS - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Current Liabilities to Capital reshapelifesciences.com|RSLS - Company Aggregate Debts|Debt to Book Value Ratio ReShape Lifesciences Inc|RSLS - Company Long-Term Debts|Short-Term Debt Volume ReShape Lifesciences|Quick Liquidity Indicator reshapelifesciences.com
- earnings and market multiples details:
RSLS - Net Profit|Projected Future Earnings ReShape Lifesciences|RSLS - Price to Earnings Ratio|Future Price to Earnings ReShape Lifesciences, Inc.|RSLS - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation ReShape Lifesciences Inc|RSLS - Operating profit EBITDA|Net earnings per one share for the last twelve months ReShape Lifesciences|RSLS - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year reshapelifesciences.com|RSLS - Net earnings per share growth this year|Earnings growth forecast for next year ReShape Lifesciences
- sales volume and revenue information:
RSLS - Revenue and Sales Volume|Company Future Sales ReShape Lifesciences Inc.|RSLS - Price-to-Revenue Ratio|Future Price to Revenue ReShape Lifesciences|RSLS - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:ReShape Lifesciences, Inc., RSLS
Manufactured product of ReShape Lifesciences, Inc.

Conservative asset selection requires minimizing fundamental risks through the analysis of profit dynamics. This indicator captures the percentage change in net income per share over twelve months, separating market noise from a sustainable trend. For ReShape Lifesciences (RSLS), this growth is driven by the robotization of equipment assembly, which reduces manual labor costs. By analyzing the annual volatility of TTM net income per share, an investor assesses the efficiency of automation. Peak values here signal the risk of a subsequent correction.

Competitor analysis for ReShape Lifesciences

Dexcom - Earnings per share for the last four quarters|PEN: Net earnings per share (EPS TTM)|NOVT - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HAE|Net earnings per share for the last 12 months Inspire Medical Systems, Inc. (INSP)|Net earnings per share for the last 12 months PRCT (PROCEPT BioRobotics Corporation)|CNMD (CONMED Corp) - Earnings per share for the trailing year|Earnings per share for the last twelve months Pulse Medical PLSE|INMD - Net earnings per share for the last 12 months|Picard Medical - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Surmodics, Inc.|SENS: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months NPCE|TCMD (Tactile Medical) - Net earnings per share (EPS TTM)|SANUWAVE Health, Inc. (SNWV) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Outset Medical, Inc. (OM)|Net earnings per share for the last 12 months Electromed ELMD|Net earnings per share (EPS TTM) LNSR (lensar.com)|Net earnings per share (EPS TTM) AVITA Medical Inc. RCEL|PROF - Earnings per share for the last twelve months|BDMD: Earnings per share for the last twelve months|EDAP (EDAP Medical) - Net earnings per share for the last 12 months|Apyx Medical Corp - Earnings per share for the trailing year|ICCM (IceCure Medical Ltd.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months pulmonx.com LUNG|Earnings per share for the last twelve months TELA Bio (TELA)|CytoSorbents Corp. (CTSO) - Net earnings per share for the trailing year|Sensus - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Zynex, Inc. ZYXI|electroCore Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Vicarious Surgical RBOT|Inspira Technologies (IINN) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months SeaStar Medical Holding Corp|Earnings per share for the last twelve months iridex.com|Net earnings per share for the last 12 months Intelligent Bio Solutions (INBS)|Net earnings per share (EPS TTM) XAIR|PFSA - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months strataskinsciences.com SSKN|GCTK: Earnings per share for the last 12 months|NAOV: Net earnings per share for the last 12 months|Venus Concept - Earnings per share for the last four quarters|CHF Solutions (NUWE) - Earnings per share for the last twelve months|Aethlon Medical, Inc. (AEMD) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Asensus Surgical|Earnings per share for the last twelve months AVGR|Earnings per share for the last twelve months BioSig (BSGM)|Earnings per share for the last four quarters CUTR|Know Labs - Net earnings per share for the last 12 months|Earnings per share for the trailing year NARI|NVRO - Earnings per share for the last twelve months|Earnings per share for the trailing year SILK (Silk Road Medical Inc)